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Soluble guanylyl cyclase (sGC) is the recognized receptor
for the nitric oxide (NO) messenger molecule. Binding of
NO to the heme moiety of sGC activates the enzyme sev-
eral hundred fold. In addition to NO several NO-inde-
pendent allosteric regulators can activate the enzyme in
heme-dependent (YC-1, BAY 41–2272) or heme-inde-
pendent (BAY 58–2667) fashions. One of the early recog-
nized NO-independent activators of sGC is
protoporphyrin IX, a tetrapyrrole compound that actively
substitutes for heme and binds to the heme-deficient sGC.
We investigated the effect of various tetrapyrrole com-
pounds on the activity of soluble guanylyl cyclase. In
agreement with previous reports sGC was highly activated
by protoporphyrin IX and was not activated by uropor-
phyrin or billirubin. The enzyme was not activated by
cobalt-PPIX or tetrapyrrole porphycene. When corrin-con-
taining compounds were tested, we found that some of
them are capable of activating sGC several fold. Pro-vita-
min factor B was among the most active corrins. Factor B-
dependent activation of sGC was synergistically enhanced
by the BAY 41–2272 compound. In the presence of BAY
41–2272 the dose response to factor B was shifted left-
ward. Measurements performed on isolated rat aortic
rings showed that factor B and several other corrins,
including vitamin B12, induces a dose-dependent relaxa-
tion, although with effective concentrations in the milli-
molar range. Tested corrins were equally effective in
endothelium competent or endothelium denudated
rings. In the presence of BAY 41–2272 the effective con-
centrations of factor B were decreased and efficient relax-
ations were achieved even with low micromolar amounts
of factor B.
Changes in blood pressure of chronically instrumented
anesthetized rats were also measured. Intravenous injec-
tion of 5 mg/kg of factor B induced a modest and transient
decrease of both diastolic and systolic blood pressure,
while 15 mg/kg showed a larger and more prolonged
response. Decreased blood pressure was associated with
increased cardiac output, suggesting vascular relaxation as
the underlying mechanism for change in blood pressure.
In corroboration with data from aortic ring relaxation,
administration of factor B in combination with BAY 41–
2272 showed the most profound and prolonged effects in
blood pressure decreases. These data suggest that corrin-
mediated activation of sGC may be a new approach in reg-
ulation of sGC activity and function. The data also suggest
that supplementary intake of vitamin B12 may influence
sGC-signaling or other treatments based on the modula-
tion of cGMP levels.
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